The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer

被引:28
|
作者
Yamamoto, Noriko [1 ,2 ]
Nishikawa, Rika [1 ]
Chiyomaru, Takeshi [3 ]
Goto, Yusuke [1 ]
Fukumoto, Ichiro [1 ]
Usui, Hirokazu [2 ]
Mitsuhashi, Akira [2 ]
Enokida, Hideki [3 ]
Nakagawa, Masayuki [3 ]
Shozu, Makio [2 ]
Seki, Naohiko [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba 2608670, Japan
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan
关键词
endometrial cancer; microRNA; microRNA-1; microRNA-133a; tumor suppressor; phosphodiesterase; 7A; CAMP-SPECIFIC PHOSPHODIESTERASE; PROTEIN-KINASE; CARCINOMA; IDENTIFICATION; EXPRESSION; ACTIVATION; MIR-1; HEAD;
D O I
10.3892/ijo.2015.2986
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In developed countries, endometrial cancer (EC) is the most common malignancy among women. Unopposed estrogen therapy, obesity, nulliparity, diabetes mellitus and arterial hypertension have been linked to an increased risk of EC. However, the molecular mechanisms of EC oncogenesis and metastasis have not yet been fully elucidated. Our recent studies of microRNA (miRNA) expression signatures revealed that the microRNA-1/133a (miR-1/133a) cluster is frequently downregulated in various types of human cancers. However, the functional role of the miR-1/133a cluster in EC cells is still unknown. Thus, the aim of this study was to investigate the functional significance of the miR-1/133a cluster and its regulated molecular targets, with an emphasis on the contributions of miR-1/133a to EC oncogenesis and metastasis. We found that the expression levels of miR-1 and miR-133a were significantly reduced in EC tissues. Moreover, restoration of mature miR-1 or miR-133a miRNAs significantly inhibited cancer cell migration and invasion, suggesting that these clustered miRNAs act as tumor suppressors. Prediction of miRNA targets revealed that phosphodiesterase 7A (PDE7A) was a potential target gene regulated by both miR-I and miR-133a. PDE7A was confirmed to be overexpressed in EC clinical specimens and silencing of PDE7A significantly inhibited cancer cell migration and invasion. Our data demonstrated that downregulation of the miR-1/133a cluster promoted cancer cell migration and invasion via overexpression of PDE7A in EC cells. Elucidation of the molecular networks regulated by tumor-suppressive miRNAs will provide insights into the molecular mechanisms of EC oncogenesis and metastasis.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 50 条
  • [21] Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting LASP1 in prostate cancer
    Nishikawa, Rika
    Goto, Yusuke
    Kinoshita, Takashi
    Sakamoto, Shinichi
    Chiyomaru, Takeshi
    Enokida, Hideki
    Kojima, Satoko
    Nakagawa, Masayuki
    Naya, Yukio
    Ichikawa, Tomohiko
    Seki, Naohiko
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer
    Yamasaki, Takeshi
    Yoshino, Hirofumi
    Enokida, Hideki
    Hidaka, Hideo
    Chiyomaru, Takeshi
    Nohata, Nijiro
    Kinoshita, Takashi
    Fuse, Miki
    Seki, Naohiko
    Nakagawa, Masayuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 1821 - 1830
  • [23] Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma
    Mizuno, Keiko
    Seki, Naohiko
    Mataki, Hiroko
    Matsushita, Ryosuke
    Kamikawaji, Kazuto
    Kumamoto, Tomohiro
    Takagi, Koichi
    Goto, Yusuke
    Nishikawa, Rika
    Kato, Mayuko
    Enokida, Hideki
    Nakagawa, Masayuki
    Inoue, Hiromasa
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (02) : 450 - 460
  • [24] TUMOR SUPPRESSIVE MICRORNA-224 INHIBITS CANCER CELL MIGRATION AND INVASION VIA TARGETING TPD52 IN PROSTATE CANCER
    Goto, Yusuke
    Nishikawa, Rika
    Kojima, Satoko
    Sakamoto, Shinichi
    Kawamura, Koji
    Imamoto, Takashi
    Chiyomaru, Takeshi
    Enokida, Hideki
    Kinoshita, Takashi
    Naya, Yukio
    Nakagawa, Masayuki
    Ichikawa, Tomohiko
    Seki, Naohiko
    JOURNAL OF UROLOGY, 2014, 191 (04): : E328 - E328
  • [25] Tumor suppressive microRNA-133a regulates novel targets: Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma
    Kinoshita, Takashi
    Nohata, Nijiro
    Fuse, Miki
    Hanazawa, Toyoyuki
    Kikkawa, Naoko
    Fujimura, Lisa
    Watanabe-Takano, Haruko
    Yamada, Yasutoshi
    Yoshino, Hirofumi
    Enokida, Hideki
    Nakagawa, Masayuki
    Okamoto, Yoshitaka
    Seki, Naohiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 418 (02) : 378 - 383
  • [26] Tumor-suppressive miR-299-3p inhibits gastric cancer cell invasion by targeting heparanase
    Zhou, Xiangjun
    Hu, Mengmou
    Ge, Zhenghui
    MOLECULAR MEDICINE REPORTS, 2019, 20 (03) : 2151 - 2158
  • [27] MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET
    Han, Chao
    Zhou, Yubing
    An, Qi
    Li, Feng
    Li, Duolu
    Zhang, Xiaojian
    Yu, Zujing
    Zheng, Lili
    Duan, Zhenfeng
    Kan, Quancheng
    TUMOR BIOLOGY, 2015, 36 (09) : 6715 - 6723
  • [28] Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma
    Yamamoto, Noriko
    Kinoshita, Takashi
    Nohata, Nijiro
    Itesako, Toshihiko
    Yoshino, Hirofumi
    Enokida, Hideki
    Nakagawa, Masayuki
    Shozu, Maki
    Seki, Naohiko
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (05) : 1523 - 1532
  • [29] MicroRNA-133a-3p inhibits cell proliferation, migration and invasion in colorectal cancer by targeting AQP1
    Kong, Bin
    Zhao, Shipeng
    Kang, Xianwu
    Wang, Bo
    ONCOLOGY LETTERS, 2021, 22 (03)
  • [30] MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway
    Qu, Wanglei
    Chen, Xiaoyan
    Wang, Jiao
    Lv, Jieqiang
    Yan, Dongsheng
    CLINICA CHIMICA ACTA, 2017, 473 : 237 - 244